Anesthesia Considerations for Placenta Accreta Spectrum

Abstract

Anesthesiologists are critical members of the multidisciplinary team managing patients with suspected placenta accreta spectrum (PAS). Preoperatively, anesthesiologists provide predelivery consultation for patients with suspected PAS where anesthetic modality and invasive monitor placement is discussed. Additionally, anesthesiologists carefully assess patient and surgical risk factors to choose an anesthetic plan and to prepare for massive intraoperative hemorrhage. Postoperatively, the obstetric anesthesiologist hold unique skills to assist with postoperative pain management for cesarean hysterectomy. We review the unique aspects of peripartum care for patients with PAS who undergo cesarean hysterectomy and explain why these responsibilities are critical for achieving successful outcomes for patients with PAS.

Key Points

• Anesthesiologists are critical members of the multidisciplinary team planning for patients with suspected placenta accreta spectrum.

• Intraoperative preparation for massive hemorrhage is a key component of anesthetic care for patients with PAS.

• Obstetric anesthesiologists have a unique skill set to manage postpartum pain and postoperative disposition for patients with PAS who undergo cesarean hysterectomy.

Keywords

anesthesia - cesarean section - hysterectomy - placenta accreta - postpartum hemorrhage

Publication History

Article published online:
19 June 2023

• References

• 1 Warrick CM, Rollins MD. Peripartum anesthesia considerations for placenta accreta. Clin Obstet Gynecol 2018; 61 (04) 808-827
• 2 Shamshirsaz AA, Fox KA, Erfani H. et al. Outcomes of planned compared with urgent deliveries using a multidisciplinary team approach for morbidly adherent placenta. Obstet Gynecol 2018; 131 (02) 234-241
• 3 Whitney SN, Holmes-Rovner M, Brody H. et al. Beyond shared decision making: an expanded typology of medical decisions. Med Decis Making 2008; 28 (05) 699-705
• 4 Goeddel LA, Porterfield Jr JR, Hall JD, Vetter TR. Ethical opportunities with the perioperative surgical home: disruptive innovation, patient-centered care, shared decision making, health literacy, and futility of care. Anesth Analg 2015; 120 (05) 1158-1162
• 5 Warrick CM, Markley JC, Farber MK. et al. Placenta Accreta Spectrum Disorders: Knowledge Gaps in Anesthesia Care. Anesth Analg 2022; 135 (01) 191-197
• 6 Walker MG, Pollard L, Talati C. et al. Obstetric and anaesthesia checklists for the management of morbidly adherent placenta. J Obstet Gynaecol Can 2016; 38 (11) 1015-1023
• 7 McQuaid-Hanson E, Pian-Smith MC. Huddles and debriefings: improving communication on labor and delivery. Anesthesiol Clin 2017; 35 (01) 59-67
• 8 Lilker SJ, Meyer RA, Downey KN, Macarthur AJ. Anesthetic considerations for placenta accreta. Int J Obstet Anesth 2011; 20 (04) 288-292
• 9 Markley JC, Farber MK, Perlman NC, Carusi DA. Neuraxial anesthesia during cesarean delivery for placenta previa with suspected morbidly adherent placenta: a retrospective analysis. Anesth Analg 2018; 127 (04) 930-938
• 10 Nguyen-Lu N, Carvalho JC, Kingdom J, Windrim R, Allen L, Balki M. Mode of anesthesia and clinical outcomes of patients undergoing cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases. Can J Anaesth 2016; 63 (11) 1233-1244
• 11 Riveros-Perez E, Wood C. Retrospective analysis of obstetric and anesthetic management of patients with placenta accreta spectrum disorders. Int J Gynaecol Obstet 2018; 140 (03) 370-374
• 12 Shamshirsaz AA, Fox KA, Salmanian B. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015; 212 (02) 218.e1-218.e9
• 13 Taylor NJ, Russell R. Anaesthesia for abnormally invasive placenta: a single-institution case series. Int J Obstet Anesth 2017; 30: 10-15
• 14 Dutky PA, Stevens SL, Maull KI. Factors affecting rapid fluid resuscitation with large-bore introducer catheters. J Trauma 1989; 29 (06) 856-860
• 15 Aeder MI, Crowe JP, Rhodes RS, Shuck JM, Wolf WM. Technical limitations in the rapid infusion of intravenous fluids. Ann Emerg Med 1985; 14 (04) 307-310
• 16 Kocaoglu N, Gunusen I, Karaman S, Ergenoglu AM, Firat V. Management of anesthesia for cesarean section in parturients with placenta previa with/without placenta accreta: a retrospective study. Ginekol Pol 2012; 83 (02) 99-103
• 17 Balayla J, Bondarenko HD. Placenta accreta and the risk of adverse maternal and neonatal outcomes. J Perinat Med 2013; 41 (02) 141-149
• 18 Butwick A, Lyell D, Goodnough L. How do I manage severe postpartum hemorrhage?. Transfusion 2020; 60 (05) 897-907
• 19 Goodnough LT, Daniels K, Wong AE, Viele M, Fontaine MF, Butwick AJ. How we treat: transfusion medicine support of obstetric services. Transfusion 2011; 51 (12) 2540-2548
• 20 Holcomb JB, Tilley BC, Baraniuk S. et al; PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015; 313 (05) 471-482
• 21 California Maternal Quality Care Collaborative (CMQCC). Improving Health Care Response to Obstetric Hemorrhage Version 2.0: A California Quality Improvement Toolkit. Accessed March 24, 2015 at: https://www.cmqcc.org/resources-tool-kits/toolkits/ob-hemorrhage-toolkit
• 22 Butwick AJ, Goodnough LT. Transfusion and coagulation management in major obstetric hemorrhage. Curr Opin Anaesthesiol 2015; 28 (03) 275-284
• 23 Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2015; 70 (02) 166-175
• 24 Henriquez DDCA, Caram-Deelder C, le Cessie S. et al; TeMpOH-1 Research Group. Association of timing of plasma transfusion with adverse maternal outcomes in women with persistent postpartum hemorrhage. JAMA Netw Open 2019; 2 (11) e1915628
• 25 Collins PW, Solomon C, Sutor K. et al. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. Br J Anaesth 2014; 113 (04) 585-595
• 26 Levy JH, Goodnough LT. How I use fibrinogen replacement therapy in acquired bleeding. Blood 2015; 125 (09) 1387-1393
• 27 de Lloyd L, Bovington R, Kaye A. et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth 2011; 20 (02) 135-141
• 28 Collins PW, Cannings-John R, Bruynseels D. et al; OBS2 study collaborators. Viscoelastometry guided fresh frozen plasma infusion for postpartum haemorrhage: OBS2, an observational study. Br J Anaesth 2017; 119 (03) 422-434
• 29 Huissoud C, Carrabin N, Audibert F. et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009; 116 (08) 1097-1102
• 30 McNamara H, Kenyon C, Smith R, Mallaiah S, Barclay P. Four years' experience of a ROTEM^® -guided algorithm for treatment of coagulopathy in obstetric haemorrhage. Anaesthesia 2019; 74 (08) 984-991
• 31 Collaborators WT. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017; 389 (10084): 2105-2116
• 32 Ahmadzia HK, Hynds EB, Amdur RL, Gimovsky AC, James AH, Luban NLC. National trends in tranexamic acid use in the peripartum period, 2015-2019. J Thromb Thrombolysis 2020; 50 (03) 746-752
• 33 Erfani H, Shamshirsaz AA, Fox KA. et al. Severe hypocalcemia during surgery for placenta accreta spectrum: the case for empiric replacement. Acta Obstet Gynecol Scand 2019; 98 (10) 1326-1331
• 34 Kyle T, Greaves I, Beynon A, Whittaker V, Brewer M, Smith J. Ionised calcium levels in major trauma patients who received blood en route to a military medical treatment facility. Emerg Med J 2018; 35 (03) 176-179
• 35 De Marchi L, Meineri M. POCUS in perioperative medicine: a North American perspective. Crit Ultrasound J 2017; 9 (01) 19
• 36 Haskins SC, Tanaka CY, Boublik J, Wu CL, Sloth E. Focused cardiac ultrasound for the regional anesthesiologist and pain specialist. Reg Anesth Pain Med 2017; 42 (05) 632-644
• 37 Ngene N, Titus J, Onyia C, Moodley J. Should uterotonic agents be avoided during cesarean hysterectomy for placenta previa accreta?. Acta Obstet Gynecol Scand 2013; 92 (11) 1338
• 38 Matsubara S. Measures for peripartum hysterectomy for placenta previa accreta: avoiding uterotonic agents and “double distal edge pickup” mass ligation. Arch Gynecol Obstet 2012; 285 (06) 1765-1767
• 39 Hoffman MS, Karlnoski RA, Mangar D. et al. Morbidity associated with nonemergent hysterectomy for placenta accreta. Am J Obstet Gynecol 2010; 202 (06) 628.e1-628.e5
• 40 Clifford L, Jia Q, Yadav H. et al. Characterizing the epidemiology of perioperative transfusion-associated circulatory overload. Anesthesiology 2015; 122 (01) 21-28
• 41 Antonelli E, Morales MA, Dumps P, Boulvain M, Weil A. Sonographic detection of fluid collections and postoperative morbidity following Cesarean section and hysterectomy. Ultrasound Obstet Gynecol 2004; 23 (04) 388-392
• 42 Hoppenot C, Tankou J, Stair S, Gossett DR. Sonographic evaluation for intra-abdominal hemorrhage after cesarean delivery. J Clin Ultrasound 2016; 44 (04) 240-244
• 43 Howell SM, Bennion DA, Jrebi N, Wang H. Application of focused assessment ultrasound in trauma to perioperative medicine: a tool to quickly diagnose postoperative hemorrhage. Anesthesiology 2018; 129 (02) 333
• 44 Deshpande R, Montealegre-Gallegos M, Matyal R, Belani K, Chawla N. Training the anesthesiologist in point-of-care ultrasound. Int Anesthesiol Clin 2016; 54 (01) 71-93
• 45 Ursprung E, Oren-Grinberg A. Point-of-care ultrasound in the perioperative period. Int Anesthesiol Clin 2016; 54 (01) 1-21
• 46 Einerson BD, Branch DW. Surgical management of placenta accreta spectrum. Clin Obstet Gynecol 2018; 61 (04) 774-782
• 47 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. 196: Thromboembolism in Pregnancy. Obstet Gynecol 2018; 132 (01) e1-e17
• 48 Salicath JH, Yeoh EC, Bennett MH. Epidural analgesia versus patient-controlled intravenous analgesia for pain following intra-abdominal surgery in adults. Cochrane Database Syst Rev 2018; 8 (08) CD010434
• 49 Bonnet MP, Mignon A, Mazoit JX, Ozier Y, Marret E. Analgesic efficacy and adverse effects of epidural morphine compared to parenteral opioids after elective caesarean section: a systematic review. Eur J Pain 2010; 14 (09) 894.e1-894.e9
• 50 Lim Y, Jha S, Sia AT, Rawal N. Morphine for post-caesarean section analgesia: intrathecal, epidural or intravenous?. Singapore Med J 2005; 46 (08) 392-396
• 51 Sutton CD, Carvalho B. Optimal pain management after cesarean delivery. Anesthesiol Clin 2017; 35 (01) 107-124
• 52 Osmundson SS, Min JY, Grijalva CG. Opioid prescribing after childbirth: overprescribing and chronic use. Curr Opin Obstet Gynecol 2019; 31 (02) 83-89
• 53 Leffert L, Butwick A, Carvalho B. et al; members of the SOAP VTE Taskforce. The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants. Anesth Analg 2018; 126 (03) 928-944
• 54 Irwin R, Stanescu S, Buzaianu C. et al. Quadratus lumborum block for analgesia after caesarean section: a randomised controlled trial. Anaesthesia 2020; 75 (01) 89-95
• 55 El-Boghdadly K, Desai N, Halpern S. et al. Quadratus lumborum block vs. transversus abdominis plane block for caesarean delivery: a systematic review and network meta-analysis. Anaesthesia 2021; 76 (03) 393-403
• 56 Wang Y, Zeng H, Guo XY, Rong XY. [Anesthetic choice for patients undergoing cesarean section complicated with placenta implantation]. Beijing Da Xue Xue Bao 2017; 49 (02) 322-325
• 57 Binici O, Büyükfırat E. Anesthesia for cesarean section in parturients with abnormal placentation: a retrospective study. Cureus 2019; 11 (06) e5033